GSK Gebro Consumer Healthcare GmbH

Haleon Gebro Consumer Healthcare (formerly GSK Gebro Consumer Healthcare GmbH) is a strategic joint venture between the global consumer health leader Haleon and the Austrian pharmaceutical company Gebro Pharma. Based in Fieberbrunn, Austria, the company focuses on the marketing and distribution of a diverse portfolio of over-the-counter (OTC) medicines and consumer health products. Its offerings include globally recognized brands such as Voltaren, Sensodyne, Otrivin, and Panadol, which serve key therapeutic areas including pain management, oral health, and respiratory care. The partnership leverages Haleon's global innovation and brand strength alongside Gebro Pharma's deep-rooted local expertise and distribution infrastructure. Following the 2022 demerger of GSK's consumer healthcare business, the entity continues to operate as a vital player in the Austrian healthcare market under its updated corporate identity.